QuickView for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=8711F09FF6886861EE51781057652251;jsessionid=F291C25A4EC476D5F065DEA4BC70B6BB;jsessionid=0846E573C6C4FC5192A1664A9F26800B;jsessionid=D7BA847F2D6F1D4FBED4988CBABA3BAA;jsessionid=9EA7469B2D056526E253E4FC27858801;jsessionid=F980689D652E876DBE6193AAD5B40067;jsessionid=E36F991577FCD2601F1E98AA95954F80;jsessionid=CE45C944E2325978379D31B5696E98CF (gene)

1. Computational analysis predicts the Kaposi's sarcoma-associated herpesvirus tegument protein ORF63 t…
2. Disruption of Prostaglandin E2 Signaling in Cancer-Associated Fibroblasts Limits Mammary Carcinoma G…
3. Stability of varicella-zoster virus open reading frame 63.
4. Varicella-zoster virus ORF63 inhibits apoptosis of primary human neurons.
5. Regions of the varicella-zoster virus open reading frame 63 latency-associated protein important for…

There were no clinical trials for TAKL;jsessionid=40E22499564EAE7F71FA29AA19705F76;jsessionid=787005E39F3AFF5E382EC41A340AB170;jsessionid=C367D95CAF574A9239FE4295078310FA;jsessionid=ED732D6F8E2B55D44E4470C64FCAE073;jsessionid=369D0FFBC2D87636BB1B0994D6332FBD;jsessionid=86EE8D8B6B703E6EEBA3A5B918311149;jsessionid=49BA9F47674F5003A9EB16565D277BA0;jsessionid=64A2860A58E179D654B41B3CA32D5353;jsessionid=8711F09FF6886861EE51781057652251;jsessionid=F291C25A4EC476D5F065DEA4BC70B6BB;jsessionid=0846E573C6C4FC5192A1664A9F26800B;jsessionid=D7BA847F2D6F1D4FBED4988CBABA3BAA;jsessionid=9EA7469B2D056526E253E4FC27858801;jsessionid=F980689D652E876DBE6193AAD5B40067;jsessionid=E36F991577FCD2601F1E98AA95954F80;jsessionid=CE45C944E2325978379D31B5696E98CF